Emphysème
Peer reviewed by Dr Surangi Mendis, MRCGPLast updated by Dr Philippa Vincent, MRCGPLast updated 2 Jun 2023
Répond aux besoins du patient lignes directrices éditoriales
- TéléchargerTélécharger
- Partager
In this series:Chronic obstructive pulmonary diseaseSpirometryInhalers for COPDMucolyticsOral bronchodilatorsAcute exacerbations of COPD
L'emphysème est une affection pulmonaire progressive qui constitue une forme de maladie pulmonaire obstructive chronique. Le tabagisme est la cause la plus fréquente de l'emphysème.
Dans cet article :
Poursuivre la lecture ci-dessous
What is emphysema?
Emphysema is a lung condition that causes shortness of breath and cough. Over time, the inner walls of the air sacs in the lungs (alveoli) are weakened and the lining of the alveoli becomes damaged. This causes a smaller number of larger air spaces instead of lots of normal small ones.
The smaller number of larger air sacs causes a reduction in the overall surface area of the lungs. This means that less oxygen can be transferred from the air being breathed into the lungs into the bloodstream.
Most people with emphysema also have a condition called chronic bronchitis. Chronic bronchitis causes inflammation in the tubes (bronchi) that carry the air to and from the lungs. This leads to a persistent cough and further reduces the air that is breathed into the lungs. Emphysema and chronic bronchitis are the two conditions that make up chronic obstructive pulmonary disease (COPD).
Sélection de patients pour Maladie pulmonaire obstructive chronique

Poitrine et poumons
Comment gérer la BPCO pendant l'hiver
La BPCO est le résultat d'un rétrécissement, d'une détérioration ou d'une inflammation des poumons. Elle est le plus souvent causée par le tabagisme. Toutefois, 20 % des personnes atteintes de BPCO n'ont jamais fumé. La maladie peut être prise en charge par des médicaments et des changements de mode de vie, mais il est important de savoir comment gérer les poussées lorsque des températures extrêmes surviennent et que le corps devient plus sensible aux infections.
par Emily Jane Bashforth

Poitrine et poumons
Maladie pulmonaire obstructive chronique
La bronchopneumopathie chronique obstructive (BPCO) est une affection pulmonaire de longue durée caractérisée par une obstruction du flux d'air vers les poumons. Les symptômes comprennent la toux et l'essoufflement. La maladie est le plus souvent causée par le tabagisme et le traitement le plus important est d'arrêter de fumer. Les inhalateurs sont couramment utilisés pour soulager les symptômes. D'autres traitements tels que les stéroïdes, les antibiotiques, l'oxygène et les médicaments amincissant le mucus (mucolytiques) sont parfois prescrits dans les cas les plus graves ou lors d'une poussée (exacerbation) des symptômes.
par le Dr Toni Hazell, MRCGP
Emphysema symptoms
The main symptoms of emphysema are shortness of breath and a cough, which usually begin gradually. As the emphysema in the lungs becomes worse, the symptoms also deteriorate.
Emphysema is a long-term condition that usually progresses over a number of years. Progress is often slow but can be faster in some people. There may be no symptoms for a long time and sometimes emphysema is found on chest x-rays even in people with no or few symptoms.
As the shortness of breath and the cough become progressively worse, it can become difficult to continue with normal activities and mobility. Emphysema eventually causes shortness of breath even at rest.
Poursuivre la lecture ci-dessous
Stages of emphysema / COPD
Stage 1 - mild
Lung function is reduced to around 80% and symptoms are mild. They can often be assumed to be "just a smoker's cough". The cough increases at this stage and often there is production of phlegm. The most important action in this mild stage is to stop smoking which can reduce the worsening of emphysema. Exercise is important as well to try and increase the functioning of the lungs.
Stage 2 - moderate
Lung function is reduced to between 50 and 79%. This is the commonest stage for emphysema and COPD to be diagnosed as the symptoms are more troublesome. The symptoms are usually the same as in mild emphysema but more persistent with daily cough and phlegm.
Stage 3 - severe
Lung function is reduced to between 30 and 49% of normal. Symptoms are worse and more frequent at this stage. It is common to get more frequent infections as the lungs are no longer able to work to expel bacteria and viruses. It is usually difficult at this stage to exercise without getting out of breath very quickly.
Stage 4 - very severe
Lung function is reduced to less than 30%. This stage is also called "end-stage" emphysema or "end-stage" COPD because it is so severe and can be life-threatening; however, it is common to live for several years at this stage, but with reduced quality of life. Weight loss is common at this stage.
How common is emphysema?
In the UK it is thought that around 1.2 million people have COPD. This number represents 2 out of every 100 of the population, or between 4-5 out of 100 of all people aged over 40. It is much commoner in the North of England and in deprived areas. The rates of emphysema and COPD in the 10% most-deprived areas is double that in the least-deprived areas. The numbers of people with emphysema and COPD has not decreased in recent years, unlike most chronic health conditions.
Poursuivre la lecture ci-dessous
Risk factors for and causes of emphysema
Factors that increase the risk of developing emphysema include:
Smoking. Emphysema is most likely to develop in cigarette smokers; however, cigar and pipe smokers also are susceptible. The risk for all types of smokers increases with the number of years and amount of tobacco smoked. Around 50% of smokers will develop emphysema with around 20% of smokers developing more severe symptoms. 80% of deaths from COPD are related to smoking.
Age. Although the lung damage that occurs in emphysema develops gradually, most people with tobacco-related emphysema begin to experience symptoms of the disease between the ages of 40 and 60.
Passive smoking. This means breathing in the smoke from someone else's cigarette, pipe or cigar. Being around secondhand smoke increases the risk of emphysema.
Exposure to fumes or dust. People breathing fumes from certain chemicals or dust from grain, cotton, wood or mining products, are more likely to develop emphysema. This risk is even greater if they also smoke.
Exposure to indoor and outdoor pollution. Breathing indoor pollutants (such as fumes from heating fuel), as well as outdoor pollutants (such as car exhaust) increases the risks of emphysema.
Alpha-1-antitrypsin deficiency. There is a rare genetic disorder called alpha-1-antitrypsin deficiency which leads to an inherited deficiency of a protein which protects the elastic structures in the lungs. People with this condition have a significantly higher risk of emphysema at a young age if they smoke. This can be diagnosed with a simple blood test.
Diagnosing emphysema
Quels sont les tests nécessaires ?
The most common test used in helping to diagnose the condition is called spirometry. Other tests include a chest X-ray and blood tests to help exclude other serious conditions. Occasionally, a special computerised tomography (CT) scan of the chest - high-resolution CT - is needed.
Emphysema treatment
The most important part of treatment is to reduce exposure to any cause - particularly to avoid smoking, including passive smoking. The treatment for many people with emphysema is the same as for chronic obstructive pulmonary disease (COPD) and includes inhalers and tablets to try and reduce the volume of phlegm produced.
Surgery (such as lung volume reduction surgery or a lung transplant) may be considered for advanced severe emphysema.
In the UK, the National Institute for Health and Care Excellence (NICE) recommends that endobronchial valve insertion to reduce lung volume can be considered as a treatment option. An endobronchial valve is a small one-way valve, which is placed in an airway (bronchus), usually using a bronchoscope. The valve allows air to flow out of the lung when breathing out but blocks air from entering that lung when breathing in. This helps to remove the excess air that is trapped in the lungs in emphysema.
Complications of emphysema
People who have emphysema are also more likely to develop:
Chest infections. These can occur frequently.
Collapsed lung (pneumothorax). A collapsed lung can be life-threatening in people who have severe emphysema, because the function of their lungs is already so compromised. This is uncommon but serious when it occurs.
Heart problems. Emphysema can increase the pressure in the arteries that connect the heart and lungs. This can cause failure of the right side of the heart, which pumps blood to the lungs (this condition is called cor pulmonale).
Large holes in the lungs (bullae). The bullae can be as very large. These bullae reduce the transfer of oxygen into the bloodstream and also increase the risk of a pneumothorax.
Preventing emphysema
This risk of emphysema can be greatly reduced by:
Ne pas fumer.
Avoiding passive smoking.
Wearing a mask to protect the lungs if working with chemical fumes or dust.
Autres lectures et références
- Pahal P, Sharma S; Emphysema. StatPearls Publishing. 2018.
- Visca D, Aiello M, Chetta A; Cardiovascular function in pulmonary emphysema. Biomed Res Int. 2013;2013:184678. doi: 10.1155/2013/184678. Epub 2013 Dec 3.
- Insertion d'une valve endobronchique pour réduire le volume pulmonaire dans l'emphysèmeNICE Interventional procedure guidance, décembre 2017
- Fondation britannique du poumonStatistiques sur la bronchopneumopathie chronique obstructive (BPCO), 2019.
Historique de l'article
Les informations contenues dans cette page sont rédigées et évaluées par des cliniciens qualifiés.
Prochaine révision prévue : 12 mai 2028
2 Jun 2023 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets liés à la santé.

Vous ne vous sentez pas bien ?
Évaluez gratuitement vos symptômes en ligne